TSC Alliance Endowment Fund

The TSC Alliance Endowment Fund operates as a distinct fiduciary entity, specifically established to receive and strategically invest philanthropic contributions. This investment mechanism is designed to generate long-term financial support for critical research initiatives and programs focused on Tuberous Sclerosis Complex (TSC). Through its funding, the Endowment Fund catalyzes the development of new therapeutic avenues, such as advancing mTORC1 selective inhibitors, directly contributing to a deeper understanding and improved treatments for the rare genetic disorder.

The Endowment Fund originated from the broader mission of the TSC Alliance, an organization dedicated to addressing Tuberous Sclerosis Complex for decades. Recognizing the imperative for sustainable financial resources to pursue a cure, the Endowment Fund was created to ensure continuous investment in scientific inquiry and medical breakthroughs. This strategic foresight provides a stable base, allowing the Alliance to consistently push the boundaries of research without relying solely on annual fundraising cycles.

The primary beneficiaries of the Endowment Fund's activities are individuals living with Tuberous Sclerosis Complex, their families, and the scientific community working to combat the disease. Its overarching vision aligns with the TSC Alliance's goal to significantly enhance the quality of life for all affected, driving research toward definitive cures and expanding vital support systems. The fund remains committed to securing a future where advancements in TSC treatment and care are perpetually supported.